111 related articles for article (PubMed ID: 4703127)
1. Evaluation of aniline mustard in patients with multiple myeloma.
Kyle RA; Costa G; Cooper MR; Ogawa M; Silver RT; Glidewell O; Holland JF
Cancer Res; 1973 May; 33(5):956-60. PubMed ID: 4703127
[No Abstract] [Full Text] [Related]
2. Evaluation of tryptophan mustard (NSC-62403) in patients with plasmacytic myeloma.
Kyle RA; Carbone PP; Lynch JJ; Owens AH; Costa G; Silver RT; Cuttner J; Harley JB; Leone LA; Shnider BI; Holland JF
Cancer Res; 1967 Mar; 27(3):510-5. PubMed ID: 5336511
[No Abstract] [Full Text] [Related]
3. [Therapeutic experiences in multiple myeloma].
Sonntag R; Favre E; Martz G
Schweiz Med Wochenschr; 1972 Nov; 102(44):1588-9. PubMed ID: 4566555
[No Abstract] [Full Text] [Related]
4. The efficacy and toxicity of bendamustine in recurrent multiple myeloma after high-dose chemotherapy.
Knop S; Straka C; Haen M; Schwedes R; Hebart H; Einsele H
Haematologica; 2005 Sep; 90(9):1287-8. PubMed ID: 16154860
[TBL] [Abstract][Full Text] [Related]
5. Influence of platelet count on haemostatic plug formation and plug stability. An experimental study in rabbits with graded thrombocytopenia.
Bergqvist D; Arfors KE
Thromb Diath Haemorrh; 1973 Dec; 30(3):586-96. PubMed ID: 4787674
[No Abstract] [Full Text] [Related]
6. Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone.
Kyle RA; Pajak TF; Henderson ES; Nawabi IU; Brunner K; Henry PH; McIntyre OR; Holland JF
Cancer Treat Rep; 1982 Mar; 66(3):451-6. PubMed ID: 7060034
[TBL] [Abstract][Full Text] [Related]
7. [Correlations between chemical structure and biological activity of azomethines with nitrogen-mustard-groups on Ehrlich ascites tumor in albino mice. 3. Activation of N-mustard-azomethines by cells of Ehrlich ascites carcinoma].
Schulze W; Horn G
Arzneimittelforschung; 1970 Mar; 20(3):329-35. PubMed ID: 5467506
[No Abstract] [Full Text] [Related]
8. [The results of a clinical study of asafan].
Karev NI; Lichinitser MR; Moroz LV; Astrakhan VI; Beroeva GV; Blokhina NG; Buk IM
Vopr Onkol; 1970 May; 16(5):41-5. PubMed ID: 5450810
[No Abstract] [Full Text] [Related]
9. [Comparative evaluation of results of treatment of patients with multiple myeloma with fractional doses of sarcolysine and asaline].
Kruglova GV; Merkulova NV; Panicheva EA
Probl Gematol Pereliv Krovi; 1969 Feb; 14(2):21-4. PubMed ID: 5351083
[No Abstract] [Full Text] [Related]
10. Phase II evaluation of mitozolomide in ovarian cancer.
Harding M; Northcott D; Smyth J; Stuart NS; Green JA; Newlands E
Br J Cancer; 1988 Jan; 57(1):113-4. PubMed ID: 3348943
[No Abstract] [Full Text] [Related]
11. [Treatment of myeloma].
Le Chevallier PL
Therapeutique; 1971; 47(6):627-9. PubMed ID: 5571183
[No Abstract] [Full Text] [Related]
12. Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol).
Tirelli U; Crivellari D; Carbone A; Veronesi A; Galligioni E; Trovò MG; Tumolo S; Grigoletto E
Cancer Treat Rep; 1982 Nov; 66(11):1971-3. PubMed ID: 6897205
[TBL] [Abstract][Full Text] [Related]
13. Treatment of multiple myeloma.
Langley GR; Smith FM
N S Med Bull; 1967 May; 46(5):105-8. PubMed ID: 5232995
[No Abstract] [Full Text] [Related]
14. [The morphologic composition of peripheral blood following intra-arterial infusion of 5-fluorouracil and alkylating preparations in stomach cancer patients].
Chernyĭ VA
Vopr Onkol; 1970 Apr; 16(4):61-4. PubMed ID: 4989339
[No Abstract] [Full Text] [Related]
15. Combination chemotherapy of advanced murine myeloma and subsequent resistance to tumor cell challenge.
Teller MN; Bowie M; Mountain IM; Stock CC
J Natl Cancer Inst; 1974 Mar; 52(3):667-71. PubMed ID: 4857022
[No Abstract] [Full Text] [Related]
16. [Effect of a new cytostatic agent (peptichemio) on malignant neoplasms].
Pittermann E; Stacher A; Griendl W
Wien Med Wochenschr; 1974 Apr; 124(14):216. PubMed ID: 4522966
[No Abstract] [Full Text] [Related]
17. A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder.
Blackledge G; Roberts JT; Kaye S; Taylor R; Williams J; de Stavola B; Uscinska B
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):391-2. PubMed ID: 2702992
[No Abstract] [Full Text] [Related]
18. Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial.
Pönisch W; Rozanski M; Goldschmidt H; Hoffmann FA; Boldt T; Schwarzer A; Ritter U; Rohrberg R; Schwalbe E; Uhlig J; Zehrfeld T; Schirmer V; Haas A; Kreibich U; Niederwieser D;
Br J Haematol; 2008 Oct; 143(2):191-200. PubMed ID: 18752593
[TBL] [Abstract][Full Text] [Related]
19. [Results of 18 months of chemotherapy with Peptichemio].
Battelli T; Bonsignori M; Manocchi P; Perilli A
Minerva Med; 1974 Sep; 65(62):3235-43. PubMed ID: 4609310
[No Abstract] [Full Text] [Related]
20. [Treatment of severe spastic forms of bronchitis with nitrogen mustard].
Romański B; Montowska L
Pol Tyg Lek; 1974 Jun; 30(22):931-3. PubMed ID: 4840193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
